03:40 PM EST - Theralease Technologies Inc. : Has reached a milestone, demonstrating six-month accelerated stability and nine-month long term stability of its lead anti-cancer PDC, TLD-1433. Theralease Technologies Inc.
shares V.TLT are trading up $0.005 at $0.38.
